3 results
8-K
EX-99.1
COYA
Coya Therapeutics Inc
8 Aug 23
Coya Therapeutics, Inc. Provides Business Update and Reports Q2 2023 Unaudited Financial Results
7:05am
-treatment and post-treatment Positron Emission Tomography (PET) brain scans to evaluate neuroinflammation. Meaningful reductions in neuroinflammation were
8-K
EX-99.1
COYA
Coya Therapeutics Inc
12 Jun 23
Regulation FD Disclosure
5:01pm
patients and assessing Treg function, blood biomarkers, cerebrospinal fluid biomarkers (among them Aß42, Tau, and phospho-Tau), Positron Emission
- Prev
- 1
- Next